Dr. David is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1215 Lee St
Charlottesville, VA 22908Phone+1 434-924-0211Fax+1 434-982-3759
Education & Training
- University of Virginia Medical CenterResidency, Pathology-Anatomic and Clinical, 2017
- Eastern Virginia Medical SchoolClass of 2017
- University of VermontBS, Clinical Laboratory Science and Technology, 2005 - 2009
Certifications & Licensure
- FL State Medical License 2022 - 2026
- VA State Medical License 2017 - 2026
- AR State Medical License 2021 - 2022
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Dermatopathology
- American Society of Clinical PathologyMedical Technologist
Awards, Honors, & Recognition
- Pathology National Honors Society Intersociety Council for Pathology, 2016
Publications & Presentations
PubMed
- 2 citationsCutaneous Oxalosis Due to Primary Hyperoxaluria.Sophia Ly, Jonathan Rick, Rachel Goff, Bre Ana David, Jay Kincannon
The American Journal of Dermatopathology. 2022-12-01
Books/Book Chapters
Abstracts/Posters
- The Story of a Pimple: Newly Diagnosed chronic lymphocytic leukemia in a basal cell carcinoma biopsyRodrigo Valdes-Rodriguez, Bre Ana David, Alejandro Gru, ASDP 2019, The University of Virginia Medical Center Department of Dermatopathology, 10/20/2019
- MMR and PD-L1 Expression in Sebaceous Carcinoma and Basal Cell Carcinoma with Sebaceous FeaturesBre Ana David MD and Anne Mills MD, USCAP, 10/2/2019
- Pharmacological targeting of the LHRH receptor enhances hematopoietic recovery after radiation injuryBre Ana M. David, Enrico Velardi, Jarrod A. Dudakov and Marcel R.M van den brink, N/A, Memorial Sloan Kettering Cancer Center, 8/7/2014
Other
- FilaggrinDr. Bre Ana M David and Dr. Mark Wick, Pathology Outlines- Stains
http://www.pathologyoutlines.com/topic/stainsfilaggrin.html
3/2018
Research History
- PD-L1 expression in MMR Intact and Deficient Sebaceous NeoplasmsThe Muir Torre Syndrome is associated with sebaceous neoplasms. Our aim is to investigate if the more aggressive tumors which demonstrate intact MMR express PD-L1 which may be amenable to treatment with targeted immunotherapy.2018 - Present
- Particle Embolization Therapy for Osteoarthritis in the Ovine ModelInvestigating the efficacy of particle embolization in the treatment of osteoarthritis in the ovine model. This study is utilizing using a multidisciplinary approach with Interventional Radiology, Orthopedic Surgery, Pathology, and Biomechanics. Responsible for grossing/ histopathologic assessment2018 - Present
- Program ParticipantInvestigation of the effects of a novel LHRH antagonist on hematopoietic stem cell recovery after bone marrow ablation in the murine model. Analysis of the bone marrow and extra-medullary sites via ELISA, flow-cytometry, and IHC techniques.2014 - 2014
- Research AssistantInvestigation of Clozapine administration on avian embryo hypothalamic gene regulation of anorexic/orexogenic proteins, CART and NPY, respectively.2008 - 2009
Professional Memberships
- American Society of Clinical PathologyMember
- American Medical AssociationMember
- College of American PathologistsJunior member residency program representative
- Member
- Virginia Society for PathologyMember
- American Society of DermatopathologyMember and Membership Committee ad hoc representative
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: